Drug Discovery & Development
Leaders in science and engineering publications over the last decade: China and the US
Capturing the attention of policy makers and companies serving the academic research market the countries with the largest number of science and engineering (S&E) articles has significantly evolved between 2007 and 2017. China leads the list in 2017 followed by the US, a reverse from 2007, according to a May report from the NSF’s National Center for Science and Engineering Statistics.  Discuss
The National Institutes of Health launches the Symptom Science Center
The National Institutes of Health, National Institute of Nursing Research (NIH NINR) launched the Symptom Science Center on June 27th, 2019 at the NIH Campus in Bethesda, MD. This event, attended by over 500 individuals, marks a momentous occasion for both clinical and translational multidisciplinary research.  Discuss
Purchasing products: Experiences with scientists and suppliers
Recently, we asked over 900 members of the SAB to tell us more about how they purchase products through life science suppliers, and the factors that influence their selection of supplier.  Discuss
Customer service and technical support: From your perspective
Over 700 members of the SAB recently took part in a survey regarding their experiences with customer service and technical support through life science suppliers. We thought you’d like to know a little more about some of the results from this project, to understand how some of the research we conduct with your help ends up!  Discuss
UK Scientists Weigh In on Brexit and Laboratory Spending - Science Advisory Board Insights
The long road to a resolution of the Brexit situation appeared to be nearing an end earlier this year, with the deadline set for March 29 to finalize how Britain would exit the EU. A “hard” Brexit, the case if no EU-Britain agreement is reached, would remove Britain from the EU’s single market among other consequences. A “soft” exit would result in Britain remaining part of the single market, but not an EU member. With a government stalemate in Britain, the EU agreed to extend the deadline until October 31, though a deal may come sooner.  Discuss
Bioprocess Innovation: Why not?
The Science Advisory Board ® is excited to present the third piece in our trends in bioprocessing series, written by Angelo DePalma, Ph.D. This article discusses why innovations occur at such a slow pace in bioprocessing and drug development despite the rate of technological and scientific advancements.  Discuss
Tech Overview: Quadrupole LC/MS
This week The Science Advisory Board will begin our Mass Spectrometry series. A mass spectrometer (MS), known as a mass spec, is an instrument that can measure the mass of different molecules within a sample. The mass spec can take a chemical compound and convert it from a molecule into ions. These ions are then separated according to their mass to charge ratio, and finally the abundance of each ion is measured. There are numerous types of MS systems, but all have six major components: the inlet system, ionization system, a vacuum system, mass analyzer, ion detector and a data handling system.  Discuss
Extractables and Leachables in Single-Use Bioprocessing
At The Science Advisory Board ®, we recognize the important role that bioprocessing and drug development scientists play in the biopharmaceutical industry, and we value your input on the panel. We invited bioprocessing expert Angelo DePalma, Ph.D. to provide his opinion on the state of extractables and leachables in single-use bioprocessing.  Discuss
The Intersection of Life Scientists and Social Media: A Revolution
How do your peers receive information online and how do they utilize social media as a means of learning new information and sharing content? These are just a few of the questions that our colleagues at BioInformatics Inc. explored in a recent report about digital marketing to life scientists.  Discuss
The Future is Here... Applications of 3D Printing in Biopharmaceuticals
There’s some seriously cool science being developed with the help of 3D printing including transparent skulls to allow researchers to view real-time brain activity, and a sponge that “soaks up” excess chemo drugs to reduce toxic side effects. In bioprocessing and drug discovery, 3D printing has already been instrumental in changing the way the industry functions with the dawn of precision medicine and applications in single-use technologies. Applications in the medical industry are disruptive and many scientists are focused on innovations in medical devices, and regenerative medicine and tissue engineering. Manufacturing plays a vital role in supporting nearly all sectors of the global economy and 3D printing, or “additive manufacturing”, is poised to change the landscape of manufacturing in the U.S. and the world.  Discuss
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter